Chembuild Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 10.00 K
as on 14-12-2024
- Company Age 4 Year, 20 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 1008.83%
(FY 2022)
- Profit -7245.80%
(FY 2022)
- Ebitda 4992.44%
(FY 2022)
- Net Worth -1836.45%
(FY 2022)
- Total Assets 297.00%
(FY 2022)
About Chembuild Pharma
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Lovenish Sandhu and Anju serve as directors at the Company.
- CIN/LLPIN
U24100PB2021PTC052546
- Company No.
052546
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2021
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Hoshiarpur, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chembuild Pharma Private Limited offer?
Chembuild Pharma Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at Chembuild Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lovenish Sandhu  | Director | 02-Jan-2021 | Current |
| Anju | Director | 02-Jan-2021 | Current |
Financial Performance of Chembuild Pharma.
Chembuild Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1008.83% increase. The company also saw a substantial fall in profitability, with a 7245.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1836.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chembuild Pharma?
Unlock access to Chembuild Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chembuild Pharma?
Chembuild Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chembuild Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chembuild Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.